Nicholas Investment Partners LP Buys Shares of 21,791 Heska Corporation (HSKA)

Nicholas Investment Partners LP bought a new position in Heska Corporation (NASDAQ:HSKA) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 21,791 shares of the medical research company’s stock, valued at approximately $2,288,000.

Other institutional investors also recently made changes to their positions in the company. Victory Capital Management Inc. bought a new position in shares of Heska Corporation during the first quarter worth about $101,000. BNP Paribas Arbitrage SA raised its position in shares of Heska Corporation by 1,306.0% in the first quarter. BNP Paribas Arbitrage SA now owns 1,167 shares of the medical research company’s stock worth $123,000 after buying an additional 1,084 shares during the last quarter. Mason Street Advisors LLC bought a new position in shares of Heska Corporation during the first quarter worth about $144,000. Asset Management One Co. Ltd. bought a new position in shares of Heska Corporation during the first quarter worth about $153,000. Finally, PNC Financial Services Group Inc. raised its position in shares of Heska Corporation by 199.2% in the first quarter. PNC Financial Services Group Inc. now owns 1,484 shares of the medical research company’s stock worth $155,000 after buying an additional 988 shares during the last quarter. Institutional investors own 81.78% of the company’s stock.

Institutional Ownership by Quarter for Heska Corporation (NASDAQ:HSKA)

Shares of Heska Corporation (NASDAQ HSKA) traded down 2.54% during trading on Friday, reaching $92.53. 120,136 shares of the company traded hands. The firm has a market capitalization of $658.44 million, a price-to-earnings ratio of 49.56 and a beta of 0.71. The company has a 50 day moving average price of $96.66 and a 200 day moving average price of $87.77. Heska Corporation has a 12-month low of $32.26 and a 12-month high of $110.25.

Heska Corporation (NASDAQ:HSKA) last issued its quarterly earnings results on Tuesday, May 2nd. The medical research company reported $0.61 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.24 by $0.37. The firm had revenue of $30.38 million for the quarter, compared to the consensus estimate of $33.31 million. Heska Corporation had a net margin of 10.45% and a return on equity of 15.20%. The business’s revenue for the quarter was up 11.9% compared to the same quarter last year. On average, equities analysts predict that Heska Corporation will post $1.98 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: “Nicholas Investment Partners LP Buys Shares of 21,791 Heska Corporation (HSKA)” was originally posted by sleekmoney and is the property of of sleekmoney. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://sleekmoney.com/nicholas-investment-partners-lp-buys-shares-of-21791-heska-corporation-hska/1916049.html.

A number of brokerages have recently issued reports on HSKA. Zacks Investment Research upgraded shares of Heska Corporation from a “hold” rating to a “buy” rating and set a $102.00 target price on the stock in a research report on Thursday, March 2nd. B. Riley reiterated a “neutral” rating and set a $83.00 target price on shares of Heska Corporation in a research report on Friday, April 28th. Benchmark Co. reiterated a “buy” rating and set a $106.00 target price (up from $100.00) on shares of Heska Corporation in a research report on Wednesday, March 1st. Finally, Aegis began coverage on shares of Heska Corporation in a research report on Thursday, June 1st. They set a “buy” rating and a $114.50 target price on the stock. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $95.50.

In other Heska Corporation news, COO Jason A. Napolitano sold 1,100 shares of the business’s stock in a transaction on Tuesday, April 11th. The shares were sold at an average price of $102.98, for a total transaction of $113,278.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Steve Asakowicz sold 382 shares of the business’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $100.08, for a total transaction of $38,230.56. Following the sale, the executive vice president now owns 10,382 shares of the company’s stock, valued at approximately $1,039,030.56. The disclosure for this sale can be found here. Insiders have sold a total of 35,265 shares of company stock worth $3,498,183 in the last quarter. 14.70% of the stock is owned by corporate insiders.

Heska Corporation Company Profile

Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.

Want to see what other hedge funds are holding HSKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Heska Corporation (NASDAQ:HSKA).

This story was originally published by sleekmoney (https://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://sleekmoney.com/nicholas-investment-partners-lp-buys-shares-of-21791-heska-corporation-hska/1916049.html

Receive News & Ratings for Heska Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *